Skip to main content
. 2005 Sep;1(3):84–92. doi: 10.1200/jop.2005.1.3.84

Table 3.

Observed 5-year survival rates by Kaplan-Meier estimate for cancer patients at Hoag Hospital during 1986-1991 vs. 1992-1999

Tumor Type No. of Hoag Patients Hoag 5-Year Survival (%) Hoag Median Survival (months) Log-Rank Test
1986-1991 1992-1999 1986-1991 1992-1999 1986-1991 1992-1999 P
Breast 917 1986 79 84 NR NR .026
Colon 430 573 51 53 65 71 .575
Rectal 147 211 55 65 74 107 .063
Esophagus 46 77 2 12 11 11 .430
Liver 27 60 4 12 5 4 .184
Melanoma 228 362 78 79 NR NR .984
Pancreas 137 202 1 5 6 6 .0001
Stomach 62 130 12 23 9 18 .006
Thyroid 49 133 90 93 NR NR .303
Cervix 150 183 66 68 NR NR .849
Uterus 198 297 78 75 NR NR .497
Ovary 191 270 39 49 36 57 .276
Bladder 203 389 64 64 103 101 .453
Kidney 104 185 54 55 89 91 .646
Prostate 702 1539 73 85 NR NR < .0001
Testis 68 100 88 95 NR NR .308
Lung 807 1455 16 19 11 13 .012
Larynx 44 75 68 67 107 110 .944
Oral cavity 151 213 49 59 54 98 .024
Brain 127 267 25 22 13 13 .682
Hodgkin's 47 73 90 80 NR NR .849
Leukemia 97 373 24 34 13 16 .051
Lymphoma 210 453 54 54 71 72 .912
Myeloma 23 108 30 28 34 32 .834
All patients 5,487* 10,548* 52 58 70 96 < .0001
*

Excludes in situ cancer, except for bladder cancer; includes unknown stage at diagnosis, and other less common tumor types that are not listed in the table; so columns do not add up to the numbers on the bottom line. NR, not reached.